During the past decade, McLaren Central Michigan conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Central Michigan" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Central Michigan" are "Prostate Cancer" (2 trials), "Recurrent Large Cell Lung Carcinoma" (1 trials), "Recurrent Lung Adenocarcinoma" (1 trials), "Recurrent Squamous Cell Lung Carcinoma" (1 trials) and "Stage IV Large Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "McLaren Central Michigan" in a lesser frequency.

Most popular intervention types in "McLaren Central Michigan" are "Drug" (3 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Cetuximab" (1 trials), "Dose-Escalated Radiation Therapy" (1 trials) and "LHRH agonist (antagonist) therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Central Michigan" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "McLaren Central Michigan". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in McLaren Central Michigan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Central Michigan, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".